Anixa Biosciences Inc. (ANIX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Anixa Biosciences Inc.

NASDAQ: ANIX · Real-Time Price · USD
3.27
-0.02 (-0.61%)
At close: Oct 03, 2025, 3:59 PM
3.35
2.39%
After-hours: Oct 03, 2025, 07:57 PM EDT

Anixa Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Cash & Equivalents
1.27M 915K 12.36M 29.13M
Short-Term Investments
18.65M 22.93M 17.33M 6.6M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -212K n/a
Receivables
173K 270K 46K n/a
Inventory
n/a n/a -46K n/a
Other Current Assets
1.26M 1.24M n/a 275.56K
Total Current Assets
21.36M 25.36M 30.2M 36M
Property-Plant & Equipment
229K 166K 212K 253.96K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
229K 166K 212K 253.96K
Total Assets
21.59M 25.52M 30.41M 36.26M
Account Payables
525K 206K 265K 136K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 46K 39.4K
Other Current Liabilities
n/a n/a 536K 564.18K
Total Current Liabilities
2.5M 2.03M 2.04M 1.27M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 82.00
Total Long-Term Liabilities
203K 123K 175K 220.08K
Total Liabilities
2.7M 2.15M 2.21M 1.49M
Total Debt
232K 175K 221K 259.48K
Book Value
18.89M 23.37M 28.2M 34.77M
Book Value Per Share
0.59 0.75 0.93 1.22
Common Stock
322K 311K 309K 300.51K
Retained Earnings
-240.75M -228.2M -218.38M -204.79M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
20M 24.34M 29.05M 35.44M
Total Investments
18.65M 22.93M 17.33M 6.6M